isoproterenol has been researched along with nociceptin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Champion, HC; Czapla, MA; Kadowitz, PJ | 1 |
| Champion, HC; Ge, LJ; Hackler, L; Kadowitz, PJ; Kastin, AJ; Zadina, JE | 1 |
2 other study(ies) available for isoproterenol and nociceptin
| Article | Year |
|---|---|
Nociceptin, an endogenous ligand for the ORL1 receptor, decreases cardiac output and total peripheral resistance in the rat.
Topics: Adrenomedullin; Amino Acid Sequence; Animals; Blood Pressure; Cardiac Output; Dose-Response Relationship, Drug; Female; Heart Rate; Injections, Intravenous; Isoproterenol; Male; Molecular Sequence Data; Nociceptin; Nociceptin Receptor; Opioid Peptides; Peptides; Rats; Rats, Sprague-Dawley; Receptors, Opioid; Vascular Resistance | 1997 |
Endomorphin 1 and 2, endogenous ligands for the mu-opioid receptor, decrease cardiac output, and total peripheral resistance in the rat.
Topics: Animals; Calcitonin Gene-Related Peptide; Cardiac Output; Cardiotonic Agents; Female; Isoproterenol; Ligands; Male; Nociceptin; Oligopeptides; Opioid Peptides; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Vascular Resistance | 1997 |